14-87933543-TATC-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_000153.4(GALC):c.*1186_*1188delGAT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 155,638 control chromosomes in the GnomAD database, including 18,478 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.46 ( 17813 hom., cov: 0)
Exomes 𝑓: 0.58 ( 665 hom. )
Consequence
GALC
NM_000153.4 3_prime_UTR
NM_000153.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.372
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 14-87933543-TATC-T is Benign according to our data. Variant chr14-87933543-TATC-T is described in ClinVar as [Benign]. Clinvar id is 314732.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.731 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALC | NM_000153.4 | c.*1186_*1188delGAT | 3_prime_UTR_variant | 17/17 | ENST00000261304.7 | NP_000144.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALC | ENST00000261304 | c.*1186_*1188delGAT | 3_prime_UTR_variant | 17/17 | 1 | NM_000153.4 | ENSP00000261304.2 | |||
GALC | ENST00000555000.5 | n.*74+353_*74+355delGAT | intron_variant | 2 | ENSP00000450472.1 |
Frequencies
GnomAD3 genomes AF: 0.464 AC: 70340AN: 151632Hom.: 17809 Cov.: 0
GnomAD3 genomes
AF:
AC:
70340
AN:
151632
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.575 AC: 2237AN: 3888Hom.: 665 AF XY: 0.578 AC XY: 1154AN XY: 1998
GnomAD4 exome
AF:
AC:
2237
AN:
3888
Hom.:
AF XY:
AC XY:
1154
AN XY:
1998
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.464 AC: 70357AN: 151750Hom.: 17813 Cov.: 0 AF XY: 0.469 AC XY: 34796AN XY: 74146
GnomAD4 genome
AF:
AC:
70357
AN:
151750
Hom.:
Cov.:
0
AF XY:
AC XY:
34796
AN XY:
74146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1942
AN:
3460
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at